MA44413A - Composition pharmaceutique utilisée pour le traitement thérapeutique du cancer et ses complications - Google Patents

Composition pharmaceutique utilisée pour le traitement thérapeutique du cancer et ses complications

Info

Publication number
MA44413A
MA44413A MA044413A MA44413A MA44413A MA 44413 A MA44413 A MA 44413A MA 044413 A MA044413 A MA 044413A MA 44413 A MA44413 A MA 44413A MA 44413 A MA44413 A MA 44413A
Authority
MA
Morocco
Prior art keywords
complications
cancer
pharmaceutical composition
composition used
therapeutic treatment
Prior art date
Application number
MA044413A
Other languages
English (en)
Inventor
Nitcheu Guy Faustin Monkam
Original Assignee
Nitcheu Guy Faustin Monkam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1771115A external-priority patent/FR3058060B1/fr
Application filed by Nitcheu Guy Faustin Monkam filed Critical Nitcheu Guy Faustin Monkam
Publication of MA44413A publication Critical patent/MA44413A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA044413A 2016-10-31 2017-10-25 Composition pharmaceutique utilisée pour le traitement thérapeutique du cancer et ses complications MA44413A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1670645A FR3058058A1 (fr) 2016-10-31 2016-10-31 Composition pharmaceutique comprenant en tant que principe actif une combinaison de beta-elemene, de lupeol et du 2-hydroxycinnamaldehyde et/ou du 2-benzoyloxycinnalmaldehyde et/ou beta-sitosterol
FR1670666A FR3058059B1 (fr) 2016-10-31 2016-11-08 Composition pharmaceutique comprenant le beta-elemene, le lupeol et le 2-hydroxycinnamaldehyde et/ou le 2'-benzoyloxycinnalmaldehyde et/ou le beta-sitosterol et/ou la curcumine.
FR1771115A FR3058060B1 (fr) 2016-10-31 2017-10-23 Composition pharmaceutique comprenant le beta-elemene, le lupeol, le cinnamaldehyde et/ou le 2-hydroxycinnamaldehyde et/ou le 2'-benzoyloxycinnalmaldehyde et/ou le beta-sitosterol et/ou la curcumine.

Publications (1)

Publication Number Publication Date
MA44413A true MA44413A (fr) 2021-03-17

Family

ID=58401825

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044413A MA44413A (fr) 2016-10-31 2017-10-25 Composition pharmaceutique utilisée pour le traitement thérapeutique du cancer et ses complications

Country Status (11)

Country Link
US (1) US20240197755A1 (fr)
EP (1) EP3429568A1 (fr)
KR (1) KR20190077449A (fr)
CN (1) CN109562080B (fr)
CA (1) CA3043456A1 (fr)
FR (2) FR3058058A1 (fr)
IL (1) IL266623A (fr)
MA (1) MA44413A (fr)
MX (1) MX2019003685A (fr)
WO (1) WO2018078539A1 (fr)
ZA (1) ZA201902910B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109438166B (zh) * 2018-11-08 2021-06-04 石药集团远大(大连)制药有限公司 (1S,2S,4S)-β-榄香烯及其制备方法和应用
FR3100128B1 (fr) * 2019-08-30 2022-02-18 Nitcheu Guy Faustin Monkam Composition pharmaceutique destinée à inhiber l’infectiosité du VIH, à traiter le syndrome d’immunodéficience acquise (SIDA) et ses complications
EP4070786B1 (fr) * 2019-12-03 2026-01-28 Sichuan Honghe Biotechnology Co., Ltd Composition pharmaceutique contenant de l'élémène, son procédé de préparation et son utilisation
CN111909897B (zh) * 2020-08-14 2021-12-21 宜兴市人民医院 Ruvbl2在调控人脐带间质干细胞增殖和/或分化中的应用
CN113018312B (zh) * 2021-01-11 2022-12-09 南开大学 一种降低肿瘤辐射抗性的纳米放疗增敏剂及其制备方法和应用
US20220362227A1 (en) * 2021-05-11 2022-11-17 Roseman University Of Health Sciences Composition of phytonutrients for diabetes management
KR20230167257A (ko) 2022-05-31 2023-12-08 전남대학교산학협력단 1개 이상의 유효성분을 포함하는 신장섬유화증 예방, 개선 또는 치료용 조성물
CN117482049B (zh) * 2023-12-29 2024-03-26 中国人民解放军总医院海南医院 一种抗肿瘤组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU22846A1 (es) * 1998-12-29 2003-04-28 Ct De Quimica Farmaceutica Composiciones farmacéuticas y nutricionales a partir de extractos de mangifera indica l
KR20050001556A (ko) * 2003-06-25 2005-01-07 서왕식 성인병(成人病)예방 및 비만증(肥滿症) 개선제 조성물
NZ552316A (en) * 2006-12-22 2009-10-30 Fonterra Co Operative Group Dairy product and process
TW201221135A (en) * 2010-11-29 2012-06-01 Jian-Rung Cheng Treatment of female diseases, menstrual pain composition of herbal extract concentrated

Also Published As

Publication number Publication date
MX2019003685A (es) 2019-09-26
FR3058059A1 (fr) 2018-05-04
CN109562080A (zh) 2019-04-02
WO2018078539A1 (fr) 2018-05-03
CA3043456A1 (fr) 2018-05-03
EP3429568A1 (fr) 2019-01-23
IL266623A (en) 2019-07-31
ZA201902910B (en) 2020-06-24
KR20190077449A (ko) 2019-07-03
US20240197755A1 (en) 2024-06-20
FR3058058A1 (fr) 2018-05-04
FR3058059B1 (fr) 2020-07-10
CN109562080B (zh) 2022-12-20

Similar Documents

Publication Publication Date Title
EP3431105A4 (fr) Composition médicinale pour le traitement du cancer
EP3533466A4 (fr) Composition pharmaceutique pour le traitement et/ou la prévention du cancer
MA44413A (fr) Composition pharmaceutique utilisée pour le traitement thérapeutique du cancer et ses complications
EP3436002A4 (fr) Combinaisons pharmaceutiques pour le traitement du cancer
EP3555077A4 (fr) Compositions et procédés pour le traitement du cancer
MA42420A (fr) Vaccins pour le traitement et la prévention du cancer
EP3474854A4 (fr) Associations médicamenteuses pour le traitement du cancer
EP2818482A4 (fr) Composition pharmaceutique pour le traitement et/ou la prévention du cancer
EP2818481A4 (fr) Composition pharmaceutique pour le traitement et/ou la prévention du cancer
EP2824114A4 (fr) Composition pharmaceutique pour le traitement et/ou la prévention du cancer
FR3032353B1 (fr) Composition pharmaceutique et dispositif pour le traitement de la douleur
EP3766497A4 (fr) Médicament pour le traitement de la toux
EP3462883A4 (fr) Compositions et méthodes pour le traitement du cancer
EP3363450A4 (fr) Composition de médecine traditionnelle chinoise pour le traitement du psoriasis
EP3681498A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3675874A4 (fr) Composition pharmaceutique pour le traitement des chéloïdes et ses utilisations
EP3870104A4 (fr) Méthodes et substances pour le traitement du cancer
EP3688023A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3968987A4 (fr) Méthodes et substances pour le traitement du cancer
EP3638293A4 (fr) Méthodes et compositions pour le traitement du cancer
EP3873205A4 (fr) Substances et méthodes pour le traitement du cancer
EP3403099A4 (fr) Procédés et compositions pour le traitement du cancer
EP3568145A4 (fr) Matériaux et méthodes pour le traitement du cancer
EP3773625A4 (fr) Méthodes et matériels pour le traitement du cancer
EP3518918A4 (fr) Méthodes et compositions pharmaceutiques pour le traitement de la stéatohépatite non alcoolique